BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2086244)

  • 1. Proenkephalin A-derived peptide E and its fragments alter opioid contractility in the small intestine.
    Davis TP; Hoyer GL; Davis P; Burks TF
    Eur J Pharmacol; 1990 Dec; 191(3):253-61. PubMed ID: 2086244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid activity of pro-enkephalin-derived peptides in mouse vas deferens and guinea pig ileum.
    Sánchez-Blázquez P; Garzón J
    Neurosci Lett; 1985 Nov; 61(3):267-71. PubMed ID: 3001596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue content of opioid peptides in the myenteric plexus-longitudinal muscle of guinea-pig small intestine.
    Corbett AD; McKnight AT; Kosterlitz HW
    J Neurochem; 1988 Jul; 51(1):32-7. PubMed ID: 3379412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide E and other proenkephalin-derived peptides are potent kappa opiate receptor agonists.
    Quirion R; Weiss AS
    Peptides; 1983; 4(4):445-9. PubMed ID: 6316294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proenkephalin A fragments exhibit spinal and supraspinal opioid activity in vivo.
    Dray A; Nunan L; Wire W
    J Pharmacol Exp Ther; 1985 Dec; 235(3):670-6. PubMed ID: 3001272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cys(O2NH2)2]enkephalin analogues and dalargin: selectivity for delta-opioid receptors.
    Pencheva N; Bocheva A; Dimitrov E; Ivancheva C; Radomirov R
    Eur J Pharmacol; 1996 May; 304(1-3):99-108. PubMed ID: 8813590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological properties of a proenkephalin A-derived opioid peptide: BAM 18.
    Hurlbut DE; Evans CJ; Barchas JD; Leslie FM
    Eur J Pharmacol; 1987 Jun; 138(3):359-66. PubMed ID: 3040439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in opioid receptor selectivity following processing of peptide E: effect on gut motility.
    Davis TP; Gillespie TJ; Shook J; Kramer TH; Hoyer G; Hawkins K; Davis P; Yamamura HI; Burks TF
    Gastroenterology; 1991 Jun; 100(6):1603-15. PubMed ID: 1850373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioligands for probing opioid receptors.
    Paterson SJ; Corbett AD; Gillan MG; Kosterlitz HW; McKnight AT; Robson LE
    J Recept Res; 1984; 4(1-6):143-54. PubMed ID: 6098650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proenkephalin A fragment, peptide E: central processing and CNS activity in vivo.
    Davis TP; Porreca F; Burks TF; Dray A
    Eur J Pharmacol; 1985 May; 111(2):177-83. PubMed ID: 2990950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor.
    Corbett AD; Gillan MG; Kosterlitz HW; McKnight AT; Paterson SJ; Robson LE
    Br J Pharmacol; 1984 Sep; 83(1):271-9. PubMed ID: 6091824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacological profile of BAM 18.
    Hurlbut DE; Evans CJ; Barchas JD; Leslie FM
    NIDA Res Monogr; 1986; 75():81-4. PubMed ID: 2829012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for lack of modulation of mu-opioid agonist action by delta-opioid agonists in the mouse vas deferens and guinea-pig ileum.
    Elliott J; Traynor JR
    Br J Pharmacol; 1995 Mar; 114(5):1064-8. PubMed ID: 7780641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative potency of enkephalins and beta-endorphin in guinea-pig ileum, mouse vas deferens and rat vas deferens after the administration of peptidase inhibitors.
    Kuno Y; Aoki K; Kajiwara M; Ishii K; Oka T
    Jpn J Pharmacol; 1986 Jul; 41(3):273-81. PubMed ID: 3761746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens.
    Sagan S; Corbett AD; Amiche M; Delfour A; Nicolas P; Kosterlitz HW
    Br J Pharmacol; 1991 Oct; 104(2):428-32. PubMed ID: 1665735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro pharmacology of the opioid peptides, enkephalins and endorphins.
    Waterfield AA; Smokcum RW; Hughes J; Kosterlitz HW; Henderson G
    Eur J Pharmacol; 1977 May; 43(2):107-16. PubMed ID: 17538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Met5-enkephalin-Arg6-Phe7 inhibition of noradrenaline and acetylcholine release from peripheral organs.
    Hársing LG; Rónai AZ; Somogyi GT; Umezawa H; Bajusz S; Vizi ES
    J Auton Pharmacol; 1984 Mar; 4(1):33-43. PubMed ID: 6325463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new endogenous opioid peptide from bovine adrenal medulla: isolation and amino acid sequence of a dodecapeptide (BAM-12P).
    Mizuno K; Minamino N; Kangawa K; Matsuo H
    Biochem Biophys Res Commun; 1980 Aug; 95(4):1482-8. PubMed ID: 7417331
    [No Abstract]   [Full Text] [Related]  

  • 19. Adrenal secretion of BAM-22P, a potent opioid peptide, is enhanced in rats with acute cholestasis.
    Swain MG; MacArthur L; Vergalla J; Jones EA
    Am J Physiol; 1994 Feb; 266(2 Pt 1):G201-5. PubMed ID: 8141292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the action of putative endogenous kappa-agonists, leumorphin and rimorphin in vitro.
    Suda M; Nakao K; Yoshimasa T; Ikeda Y; Sakamoto M; Yanaihara C; Yanaihara N; Numa S; Imura H
    Life Sci; 1983; 33 Suppl 1():275-8. PubMed ID: 6319876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.